PYXS
Pyxis Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.89
+9.12%0
Insider buys (3m)
1
Insider sells (3m)
-$107.1K
Net value (3m)
+120.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 20, 2026 | Dupont Jakob · director | A-Award | 46,000 | $3.12 |
| Aug 14, 2026 | Civik Thomas · director, officer: Interim CEO | A-Award | 250,956 | $1.49 |
| Jul 2, 2026 | Dupont Jakob · director | Sale | 35,000 | $3.06 |
| Jul 2, 2026 | Dupont Jakob · director | M-Exempt | 35,000 | $1.60 |
| Mar 25, 2026 | Wadhane Jitendra · officer: Prin Fin & Acct Officer | A-Award | 262,635 | $1.36 |
| Mar 25, 2026 | Wadhane Jitendra · officer: Prin Fin & Acct Officer | A-Award | 109,461 | $0.00 |
| Mar 25, 2026 | Dupont Jakob · director | A-Award | 45,867 | $1.36 |
| Mar 25, 2026 | HUMPHREY RACHEL · director | Sale | 13,896 | $1.03 |
| Mar 25, 2026 | HUMPHREY RACHEL · director | Sale | 200 | $0.97 |
| Mar 25, 2026 | HUMPHREY RACHEL · director | Sale | 1,400 | $0.97 |
| Mar 25, 2026 | Palani Santhosh · director | A-Award | 45,867 | $1.36 |
| Mar 25, 2026 | HUMPHREY RACHEL · director | A-Award | 45,867 | $1.36 |
| Mar 25, 2026 | Cline Darren S · director | A-Award | 45,867 | $1.36 |
| Mar 25, 2026 | Lewis-Hall Freda C · director | A-Award | 45,867 | $1.36 |
| Mar 25, 2026 | Metzger Michael A · director | A-Award | 45,867 | $1.36 |
| Mar 25, 2026 | FLAVIN JOHN L · director | A-Award | 45,867 | $1.36 |
| Feb 5, 2026 | Civik Thomas · director, officer: Interim CEO | A-Award | 690,131 | $1.49 |
| Apr 2, 2025 | HUMPHREY RACHEL · director | A-Award | 36,979 | $0.98 |
| Apr 2, 2025 | Wadhane Jitendra · officer: SVP, Chief Accounting Officer | A-Award | 263,782 | $0.98 |
| Apr 2, 2025 | Dupont Jakob · director | A-Award | 36,979 | $0.98 |
| Apr 2, 2025 | Palani Santhosh · director | A-Award | 36,979 | $0.98 |
| Apr 2, 2025 | Civik Thomas · director | A-Award | 36,979 | $0.98 |
| Apr 2, 2025 | Connealy Pamela Ann · officer: CFO & COO | A-Award | 414,163 | $0.98 |
| Apr 2, 2025 | FLAVIN JOHN L · director | A-Award | 36,979 | $0.98 |
| Apr 2, 2025 | Sullivan Lara · director, officer: President ,CEO & CMO | A-Award | 918,308 | $0.98 |
| Apr 2, 2025 | Metzger Michael A · director | A-Award | 36,979 | $0.98 |
| Apr 2, 2025 | Lewis-Hall Freda C · director | A-Award | 36,979 | $0.98 |
| Apr 2, 2025 | Cline Darren S · director | A-Award | 36,979 | $0.98 |
| Dec 23, 2024 | Wadhane Jitendra · officer: SVP, Chief Accounting Officer | A-Award | 150,000 | $1.67 |
| Dec 23, 2024 | Sullivan Lara · director, officer: Chief Executive Officer | A-Award | 1,135,000 | $1.67 |
Institutional positioning
13F filings over the trailing two quarters
New 15Increased 10Reduced 39Sold out 76
| Filer | Action | Shares | Filed |
|---|---|---|---|
| PFIZER INC | Unchanged | 7,032,770 | May 12, 2026 |
| LAURION CAPITAL MANAGEMENT LP | Reduced | 4,997,333 | May 14, 2026 |
| GordonMD Global Investments LP | Unchanged | 4,121,870 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,033,510 | May 15, 2026 |
| PALO ALTO INVESTORS LP | Reduced | 1,010,510 | May 15, 2026 |
| 683 CAPITAL MANAGEMENT, LLC | Increased | 896,263 | May 15, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 888,680 | May 14, 2026 |
| BLACKROCK, INC. | Increased | 788,839 | May 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 598,121 | May 15, 2026 |
| LONGAEVA PARTNERS L.P. | Unchanged | 503,214 | May 15, 2026 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | New Position | 460,997 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Reduced | 397,625 | May 15, 2026 |
| MARSHALL WACE, LLP | Reduced | 354,417 | May 15, 2026 |
| JANE STREET GROUP, LLC | Reduced | 329,959 | May 12, 2026 |
| DECHENG CAPITAL LLC | Unchanged | 326,810 | May 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 20, 2026